Caprolactam Chem

{
  "main_header": {
    "sid": 320725,
    "name": "Caprolactam Chem",
    "stock_name": "Caprolactam Chem",
    "full_name": "Caprolactam Chemicals Ltd",
    "name_url": "stocks-analysis/caprolactam-chem",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "51.29",
    "chg": -0.01,
    "chgp": "-0.02%",
    "dir": -1,
    "prev_price": "51.30",
    "mcapval": "24.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 507486,
    "symbol": "",
    "ind_name": "Commodity Chemicals",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE470N01010",
    "curr_date": "Apr 28",
    "curr_time": "",
    "bse_nse_vol": "470 ",
    "exc_status": "Active",
    "traded_date": "Apr 28, 2026",
    "traded_date_str": "2026 04 28",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/caprolactam-chem-320725-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Caprolactam Chemicals Ltd Valuation Shifts Signal Price Attractiveness Concerns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caprolactam-chemicals-ltd-valuation-shifts-signal-price-attractiveness-concerns-3956513",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CaprolactamChem_valuationdot_3956513.png",
        "date": "2026-04-22 08:00:28",
        "description": "Caprolactam Chemicals Ltd, a micro-cap player in the commodity chemicals sector, has witnessed a significant shift in its valuation parameters, raising questions about its price attractiveness amid a volatile market backdrop. The company’s price-to-earnings (P/E) ratio has surged to an extraordinary 2,688.7, while its price-to-book value (P/BV) stands at 5.05, marking a transition from fair to expensive valuation territory. This article analyses these valuation changes in the context of historical trends, peer comparisons, and broader market performance to provide investors with a comprehensive perspective."
      },
      {
        "title": "Caprolactam Chemicals Ltd: Valuation Shifts Signal Changing Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caprolactam-chemicals-ltd-valuation-shifts-signal-changing-price-attractiveness-3946421",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CaprolactamChem_valuationdot_3946421.png",
        "date": "2026-04-15 08:00:44",
        "description": "Caprolactam Chemicals Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair rating despite its sky-high price-to-earnings (P/E) ratio. This transition reflects a complex interplay of market sentiment, financial metrics, and sector comparisons, raising important considerations for investors navigating the commodity chemicals space."
      },
      {
        "title": "Caprolactam Chemicals Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caprolactam-chemicals-ltd-valuation-shifts-signal-renewed-price-attractiveness-3933593",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/CaprolactamChem_valuationdot_3933593.png",
        "date": "2026-04-06 08:00:23",
        "description": "Caprolactam Chemicals Ltd, a micro-cap player in the commodity chemicals sector, has witnessed a notable shift in its valuation parameters, moving from a previously fair to an attractive valuation grade. Despite a challenging market environment reflected in its recent share price decline, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a potential re-rating opportunity relative to its historical and peer benchmarks."
      },
      {
        "title": "Caprolactam Chemicals Ltd: Valuation Shift Signals Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/caprolactam-chemicals-ltd-valuation-shift-signals-renewed-price-attractiveness-3895521",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CaprolactamChem_valuationdot_3895521.png",
        "date": "2026-03-17 08:00:22",
        "description": "Caprolactam Chemicals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade despite a significant decline in its share price. This change reflects evolving market perceptions amid mixed financial metrics and peer comparisons within the commodity chemicals sector."
      },
      {
        "title": "Caprolactam Chemicals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/caprolactam-chemicals-ltd-is-rated-sell-3822343",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CaprolactamChem_mojoScore_3822343.png",
        "date": "2026-02-05 10:10:04",
        "description": "Caprolactam Chemicals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      }
    ],
    "total": 128,
    "sid": "320725",
    "stock_news_url": "https://www.marketsmojo.com/news/caprolactam-chemicals-320725"
  },
  "announcements": [
    {
      "caption": "Non Applicability Of Regulation 23(9) Of SEBI (LODR) Regulations 2015",
      "datetime": "22-Apr-2026",
      "details": "Non Applicability of Regulation 23(9) of SEBI (LODR) Regulations 2015",
      "source": "BSE"
    },
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "18-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Caprolactam Chemicals Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24110MH1988PLC049683</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>9.23</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>0</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Dolly Shah <br/> Designation: Company Secretary <br/> EmailId: dollymehta93@hotmail.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Siddharth Bhanushali <br/> Designation: Chief Financial Officer <br/> EmailId: ccl.siddharth.b@gmail.com</div> </div> <div> <br/> Date: 18/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "04-Apr-2026",
      "details": "Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Caprolactam Chemicals Ltd Valuation Shifts Signal Price Attractiveness Concerns

2026-04-22 08:00:28

Caprolactam Chemicals Ltd, a micro-cap player in the commodity chemicals sector, has witnessed a significant shift in its valuation parameters, raising questions about its price attractiveness amid a volatile market backdrop. The company’s price-to-earnings (P/E) ratio has surged to an extraordinary 2,688.7, while its price-to-book value (P/BV) stands at 5.05, marking a transition from fair to expensive valuation territory. This article analyses these valuation changes in the context of historical trends, peer comparisons, and broader market performance to provide investors with a comprehensive perspective.

Read full news article

Caprolactam Chemicals Ltd: Valuation Shifts Signal Changing Price Attractiveness

2026-04-15 08:00:44

Caprolactam Chemicals Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair rating despite its sky-high price-to-earnings (P/E) ratio. This transition reflects a complex interplay of market sentiment, financial metrics, and sector comparisons, raising important considerations for investors navigating the commodity chemicals space.

Read full news article

Caprolactam Chemicals Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-04-06 08:00:23

Caprolactam Chemicals Ltd, a micro-cap player in the commodity chemicals sector, has witnessed a notable shift in its valuation parameters, moving from a previously fair to an attractive valuation grade. Despite a challenging market environment reflected in its recent share price decline, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a potential re-rating opportunity relative to its historical and peer benchmarks.

Read full news article

Caprolactam Chemicals Ltd: Valuation Shift Signals Renewed Price Attractiveness

2026-03-17 08:00:22

Caprolactam Chemicals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade despite a significant decline in its share price. This change reflects evolving market perceptions amid mixed financial metrics and peer comparisons within the commodity chemicals sector.

Read full news article

Caprolactam Chemicals Ltd is Rated Sell

2026-02-05 10:10:04

Caprolactam Chemicals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

View All News